<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The initial results of a randomized clinical trial comparing intensive cyclical combination chemotherapy (CVP) and total body radiation therapy in the treatment of advanced (Stage III and IV) lymphocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> is presented </plain></SENT>
<SENT sid="1" pm="."><plain>Sixty-five patients have been entered and randomized according to stage </plain></SENT>
<SENT sid="2" pm="."><plain>Of the chemotherapy treated patients, (22/27 (81%) achieved a response with 55% complete responders </plain></SENT>
<SENT sid="3" pm="."><plain>The radiation group or those treated with radiation 27/32 (84%) responded with 56% in complete response </plain></SENT>
<SENT sid="4" pm="."><plain>There is no significant difference in overall survival between the two groups </plain></SENT>
<SENT sid="5" pm="."><plain>Nodular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (44 patients) responds more often and has s significantly longer survival than diffuse <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (21 patients) </plain></SENT>
<SENT sid="6" pm="."><plain>Approximately 50% of the complete remitters have relapsed but reinduction of disease control was possible in almost <z:hpo ids='HP_0000001'>all</z:hpo> cases </plain></SENT>
</text></document>